{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:23:40Z","timestamp":1790126620127,"version":"4.0.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011995","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T15:23:52Z","timestamp":1281453832000},"page":"e11995","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity"],"prefix":"10.1371","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct00000886","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Barney S.","family":"Graham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Rybczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent J.","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Ottinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ferarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Stablein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Duerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Fast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the AIDS Vaccine Evaluation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"key":"ref1","article-title":"Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand.","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.4049\/jimmunol.145.8.2677","article-title":"Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.","volume":"145","author":"MK Hart","year":"1990","journal-title":"J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.88.21.9448","article-title":"Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides.","volume":"88","author":"MK Hart","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/S0264-410X(01)00051-2","article-title":"A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.","volume":"19","author":"JS Lambert","year":"2001","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/JVI.74.4.1694-1703.2000","article-title":"Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.","volume":"74","author":"H Gahery-Segard","year":"2000","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/infdis\/173.2.330","article-title":"A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.","volume":"173","author":"GJ Gorse","year":"1996","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.","volume":"1","author":"J Aucouturier","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00002030-199811000-00010","article-title":"Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.","volume":"12","author":"JA Bartlett","year":"1998","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/00002030-199910220-00002","article-title":"HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients.","volume":"13","author":"LA Pinto","year":"1999","journal-title":"AIDS"},{"key":"ref10","first-page":"S74","article-title":"Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.","volume":"10","author":"RJ Trauger","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/169.6.1256","article-title":"Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells.","volume":"169","author":"RJ Trauger","year":"1994","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pt.2005.07.005","article-title":"Revisiting Freund's incomplete adjuvant for vaccines in the developing world.","volume":"21","author":"LH Miller","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.","volume":"3","author":"Y Wu","year":"2008","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.153.8.3822","article-title":"A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.","volume":"153","author":"JT Safrit","year":"1994","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JCM.26.2.231-235.1988","article-title":"Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.","volume":"26","author":"DC Montefiori","year":"1988","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1073\/pnas.94.4.1396","article-title":"Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.","volume":"94","author":"G Ferrari","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4049\/jimmunol.151.3.1646","article-title":"Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.","volume":"151","author":"BF Haynes","year":"1993","journal-title":"J Immunol"},{"key":"ref18","first-page":"33","article-title":"Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.","volume":"106","author":"BF Haynes","year":"1993","journal-title":"Trans Assoc Am Physicians"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/JVI.75.9.4165-4175.2001","article-title":"Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.","volume":"75","author":"NL Letvin","year":"2001","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1021\/bi952665x","article-title":"Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.","volume":"35","author":"HM Vu","year":"1996","journal-title":"Biochemistry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.4049\/jimmunol.151.9.5096","article-title":"Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys.","volume":"151","author":"Y Yasutomi","year":"1993","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S2-44","DOI":"10.1016\/j.vaccine.2005.01.116","article-title":"The use of oil adjuvants in therapeutic vaccines.","volume":"24","author":"J Aucouturier","year":"2006","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpeds.2007.08.039","article-title":"A case of recurrent sterile abscesses following vaccination: delayed hypersensitivity to aluminum.","volume":"152","author":"HK Lehman","year":"2008","journal-title":"J Pediatr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/intimm\/8.5.641","article-title":"Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.","volume":"8","author":"MA Alexander-Miller","year":"1996","journal-title":"Int Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:59:23Z","timestamp":1685717963000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011995"}},"subtitle":[],"editor":[{"given":"Lishomwa C.","family":"Ndhlovu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011995","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]}}}